An African strain of community methicillin-resistant Staphylococcus aureus in a Burundi refugee.
Donaldson
Annabelle
A
Gosbell
Iain B
IB
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001315:Australia; D001426:Bacterial Proteins / Q000235:genetics / Q000302:isolation & purification; D002063:Burundi / Q000208:ethnology; D002437:Cefazolin / Q000627:therapeutic use; D002981:Clindamycin / Q000627:therapeutic use; D017714:Community-Acquired Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D016106:Methicillin Resistance / Q000235:genetics; D008875:Middle Aged; D046915:Penicillin-Binding Proteins; D012036:Refugees; D013203:Staphylococcal Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology*; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification*; D016896:Treatment Outcome; D014946:Wound Infection / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology*
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D046915:Penicillin-Binding Proteins; C487789:mecA protein, Staphylococcus aureus; D002981:Clindamycin; D002437:Cefazolin